Breast cancer treatment saves lives. What it often does not do, according to a new study, is prepare women for the sexual fallout that follows. Researchers at Griffith University interviewed 31 breast cancer survivors, aged 32 to 72, about how breast cancer sexual recovery unfolds in real life, and how intimate lives change after treatment ended. The answers pointed to the same gap again and again: nobody in the hospital brought it up.

The paper, published in The Journal of Sex Research, builds what lead author Mina Esmkhani calls a three-layer model of post-treatment sexual adjustment. The first layer is embodied disruption: pain, vaginal dryness, reduced desire, scarring and altered body image. The second is relational: how a partner responds, and whether a couple can talk about what changed. The third covers the culture around cancer care itself, from social expectations and stigma to whether a doctor ever asks about sexual health at all.

"Sexual recovery is not purely a medical issue, but is also physical, emotional, relational and social," Esmkhani said.

The interviews covered women who were well past active treatment. Many were still experiencing significant sexual and intimacy challenges long after their last appointment, a sign that the gap in care extends deep into survivorship.

Three paths after treatment

One of the study's clearest findings is that women with similar treatments had very different recoveries. The researchers found three trajectories. Some women stayed in a state of disruption, describing ongoing shame, isolation and intimacy difficulties. Others adjusted gradually, working through problems with communication and support. And some reclaimed their sexuality through a renewed sense of self.

Partners emerged as one of the strongest influences on which path a woman followed, according to co-author Dr Charrlotte Seib from Griffith's School of Nursing and Midwifery. Women who reported empathy, reassurance and emotional support were more likely to adapt positively. "This shows that partners are not passive observers and can act either as a buffer against distress or intensify it through avoidance, silence or discomfort," Seib said. "A supportive partner helped women feel desired, rebuild their confidence, develop new forms of intimacy and maintain emotional connection, a dynamic echoed in research on chronic illness and intimacy."

The silence in the exam room

What frustrated participants most was not the side effects themselves but the silence around them. That silence was a consistent response, the researchers found, and it could feed feelings of shame. Women said their clinical teams focused on treatment and survival and rarely discussed sexuality, intimacy or sexual side effects.

Senior author Associate Professor Armin Ariana, an accredited clinical sexologist at Griffith's School of Medicine and Dentistry, said sexual health remains a major gap in breast cancer care. "Many women felt they had nowhere to seek advice about painful sex, loss of desire, body image concerns or relationship challenges," Ariana said. "Sexual health needs to be built into standard cancer care conversations, not treated as an optional extra raised only if the patient brings it up first. This is exactly what we need to be teaching the next generation of doctors, to ask the question before the patient has to."

The problem is not limited to breast cancer. In a separate qualitative study published in Supportive Care in Cancer, 21 gynecologic oncology providers described how inconsistently sexual health comes up with patients, even though guidelines from the National Comprehensive Cancer Network have called for sexual health screening in cancer care since 2013 and the American Society of Clinical Oncology has done the same since 2018. Research has found that between 60 and 100 percent of gynecologic cancer survivors report some form of sexual dysfunction during treatment and survivorship.

What needs to change

The Griffith team's recommendation is direct: train clinicians to ask. Sexual health should be a built-in part of standard cancer care, not a topic patients have to raise themselves, and faster sexual health testing options show how routine the conversation could become. For survivors, the study's message about breast cancer sexual recovery is worth hearing plainly. Pain, dryness, changed desire and awkwardness with a partner are common consequences of treatment, and the biggest variable in recovering from them, according to the research, may be whether anyone, doctor or partner, is willing to talk about it. More detail on the study is in the original report.